⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3293682 | 0.82 | CYP11B1 (0.44) | — | |
| SCHEMBL376303 | 0.76 | — | — | |
| SCHEMBL2370987 | 0.73 | CDK2 (0.41) | — | |
| SCHEMBL138054 | 0.73 | — | — | |
| SCHEMBL11370784 | 0.71 | — | — | |
| SCHEMBL21664084 | 0.71 | — | — | |
| SCHEMBL27851416 | 0.71 | CYP11B1 (0.42) | — | |
| SCHEMBL6375657 | 0.71 | — | — | |
| SCHEMBL31227033 | 0.71 | — | — | |
| SCHEMBL19555999 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108083599-A | For the foam Ti-base catalyst of sludge hot hydrolysis process system | 北京达源环保科技有限公司 | 2018-05-29 | — | — | CN | claimed |
| EP-3898646-B1 | 3.ALPHA.-HYDROXY-17.BETA.-AMIDE NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF | SAGE THERAPEUTICS LLC (US) | 2026-02-18 | — | — | EP | disclosed |
| US-20260000692-A1 | Substituted N-(Pyridin-2-yl)Acetamide Derivatives as CDK12/13 Inhibitors | AURIGENE ONCOLOGY LIMITED (IN) | 2026-01-01 | — | — | US | disclosed |
| US-12398139-B2 | Modulators of AMPA receptor signaling | CENTRE FOR ADDICTION AND MENTAL HEALTH (CA) | 2025-08-26 | — | — | US | disclosed |
| EP-4594318-A1 | AKT1 MODULATORS | Alterome Therapeutics, Inc. (US) | 2025-08-06 | — | — | EP | disclosed |
| EP-4590396-A1 | PCSK9 INHIBITORS AND METHODS OF USE THEREOF | Astrazeneca AB (SE) | 2025-07-30 | — | — | EP | disclosed |
| US-20250197421-A1 | MCL1 INHIBITORS | GILEAD SCIENCES, INC. | 2025-06-19 | — | — | US | disclosed |
| WO-2025092989-A1 | SUBSTITUTED QUINAZOLINE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMBINATION THEREOF, AND USE THEREOF | 泰州红云制药有限公司 | 2025-05-08 | — | — | WO | disclosed |
| EP-3935059-B1 | MODULATORS OF AMPA RECEPTOR SIGNALING | CAMH (CA) | 2025-04-23 | — | — | EP | disclosed |
| US-20250092040-A1 | AKT1 MODULATORS | ALTEROME THERAPEUTICS, INC. | 2025-03-20 | — | — | US | disclosed |
| EP-1256588-A1 | NOVEL PYRAZINE DERIVATIVES OR SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THE DERIVATIVES OR THE SALTS AND INTERMEDIATES FOR THE PREPARATION OF BOTH | TOYAMA CHEMICAL CO., LTD. (JP) | 2002-11-13 | — | — | EP | disclosed |
| US-20020165241-A1 | N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists | MERCK SHARP & DOHME LLC | 2002-11-07 | — | — | US | disclosed |
| WO-2002068409-A1 | N-SUBSTITUTED NONARYL-HETEROCYCLIC NMDA/NR2B ANTAGONISTS | MERCK & CO., INC. (US) | 2002-09-06 | — | — | WO | disclosed |
| EP-0747486-B1 | Microbiological method for the synthesis of heteroaromatic caboxylic acids using microorganisms of the genus Alcaligenes | LONZA AG (CH) | 1999-11-03 | — | — | EP | disclosed |
| US-5702930-A | FROM CORRESPONDING NITRILE COMPOUND | LONZA, LTD. (CH) | 1997-12-30 | — | — | US | disclosed |
| EP-0747486-A1 | Microbiological method for the synthesis of heteroaromatic caboxylic acids using microorganisms of the genus Alcaligenes | LONZA AG (CH) | 1996-12-11 | — | — | EP | disclosed |
| EP-0182111-B1 | PROCESS FOR THE PREPARATION OF PERHALOGENATED COMPOUNDS | BASF Aktiengesellschaft (DE) | 1989-09-20 | — | — | EP | disclosed |
| US-4293552-A | Novel 1-(mono-o-substituted benzoyl)-3-(substituted pyrazinyl) ureas | ELI LILLY AND COMPANY (US) | 1981-10-06 | — | — | US | disclosed |
| US-4160834-A | INSECTICIDES | ELI LILLY AND COMPANY (US) | 1979-07-10 | — | — | US | disclosed |
| US-4083977-A | Novel insecticidal 1-(substituted benzoyl)-3-(substituted pyrazinyl)ureas | ELI LILLY AND COMPANY (US) | 1978-04-11 | — | — | US | disclosed |